Free Trial
→ War on Elon Escalates… (From Porter & Company) (Ad) Free ITCI Stock Alerts

Intra-Cellular Therapies (ITCI) Insider Trading & Ownership

$74.70
-0.41 (-0.55%)
(As of 09/18/2024 ET)
Compare

Intra-Cellular Therapies (NASDAQ:ITCI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.40%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
9
Amount Of
Insider Selling
(Last 12 Months)
$50.22 M
Get ITCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Intra-Cellular Therapies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ITCI Insider Buying and Selling by Quarter

Ad Paradigm Press
Kamala’s Dirty Election Move… Revealed
According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…
Click here now and learn how to prepare.

Intra-Cellular Therapies Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/30/2024Sharon MatesCEOSell34,396$72.84$2,505,404.64  
8/27/2024Sharon MatesCEOSell40,513$73.58$2,980,946.54  
8/23/2024Sharon MatesCEOSell28,680$74.46$2,135,512.80  
8/21/2024Sharon MatesCEOSell53,013$75.65$4,010,433.45  
8/16/2024Mark NeumannEVPSell18,714$75.08$1,405,047.12  
6/24/2024Rory B RiggsDirectorSell4,462$75.57$337,193.34  
6/21/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$76.58$1,001 - $15,000
6/18/2024Nostrand Robert L VanDirectorSell20,000$75.91$1,518,200.00  
3/11/2024Lawrence J. HinelineCFOSell10,121$65.96$667,581.16  
3/11/2024Michael HalsteadEVPSell7,345$65.97$484,549.65  
3/11/2024Sharon MatesCEOSell20,565$65.21$1,341,043.65  
3/7/2024Lawrence J. HinelineCFOSell13,132$66.60$874,591.20  
3/7/2024Sharon MatesCEOSell40,712$66.50$2,707,348.00  
3/7/2024Suresh K DurgamEVPSell6,450$66.56$429,312.00  
2/26/2024Joel S MarcusDirectorSell26,328$68.68$1,808,207.04  
2/26/2024Lawrence J. HinelineCFOSell13,337$69.43$925,987.91  
2/26/2024Michael HalsteadEVPSell7,907$69.53$549,773.71  
2/26/2024Sharon MatesCEOSell22,590$69.79$1,576,556.10  
1/18/2024Sharon MatesCEOSell67,917$65.19$4,427,509.23  
1/16/2024Sharon MatesCEOSell75,361$67.25$5,068,027.25  
1/11/2024Michael HalsteadEVPSell50,000$66.83$3,341,500.00  
1/2/2024Suresh K. DurgamEVPSell62,282$70.60$4,397,109.20  
12/13/2023Suresh K. DurgamEVPSell21,262$65.00$1,382,030.00  
11/6/2023Mark NeumannEVPSell42,393$55.63$2,358,322.59  
9/18/2023Sharon MatesCEOSell55,587$53.76$2,988,357.12  
(Data available from 1/1/2013 forward)

ITCI Insider Trading Activity - Frequently Asked Questions

3.40% of Intra-Cellular Therapies stock is owned by insiders. Learn more on ITCI's insider holdings.

The following insiders have sold ITCI shares in the last 24 months: Joel S Marcus ($2,062,307.04), Lawrence J. Hineline ($15,131,817.36), Mark Neumann ($8,968,481.86), Michael Halstead ($7,062,323.36), Nostrand Robert L Van ($2,148,200.00), Rory B Riggs ($337,193.34), Sharon Mates ($36,654,828.17), and Suresh K Durgam ($1,643,805.96).

Insiders have sold a total of 1,314,137 Intra-Cellular Therapies shares in the last 24 months for a total of $79,788,096.29 sold.

Josh Gottheimer (D-NJ) has sold shares of Intra-Cellular Therapies in the last year totaling $8,000.

Intra-Cellular Therapies Key Executives

  • Dr. Sharon Mates Ph.D. (Age 71)
    Co-Founder, Chairman & CEO
    Compensation: $2.23M
  • Mr. Michael I. Halstead J.D. (Age 51)
    President
    Compensation: $983.65k
  • Dr. Suresh K. Durgam M.D. (Age 55)
    Executive VP & Chief Medical Officer
    Compensation: $961.84k
  • Mr. Mark NeumannMr. Mark Neumann (Age 61)
    EVP & Chief Commercial Officer
    Compensation: $998.36k
    1 recent trades
  • Dr. Robert E. Davis Ph.D. (Age 73)
    Senior VP & Chief Scientific Officer
    Compensation: $646.12k
  • Mr. Juan Fernando Sanchez (Age 53)
    Vice President of Corporate Communications & Investor Relations
    Compensation: $296.75k
  • Ms. Karen Patruno Sheehy Esq. (Age 62)
    Senior VP & Chief Compliance Officer
  • Dr. Michael Olchaskey
    Senior VP & Head of Regulatory Affairs
  • Mr. John A. Bardi
    Senior VP of Market Access, Policy & Government Affairs
  • Dr. Willie R. Earley M.D.
    Senior VP & Head of Clinical Development

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:

This page (NASDAQ:ITCI) was last updated on 9/18/2024 by MarketBeat.com Staff
From Our Partners
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
This diversified cannabis pioneer could make huge moves soon
The cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...
Greenlane | Sponsored
Unlock the Secret to Easy Wins with Iron Condors
Discover the power of Iron Condor trades – a low-risk, high-reward strategy that allows you to profit consiste...
Netpicks | Sponsored
Sell NVDA Now?
Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...
Chaikin Analytics | Sponsored
Crypto ‘Banana Zone’ Incoming…
What if I told you that bananas could make you a millionaire? No, this isn't a joke – I'm talking about the...
Crypto 101 Media | Sponsored
CNBC’s ‘Prophet’ issues urgent Fed warning
"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...
Stansberry Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
625,000% Gain
The recent crypto correction has shaken many investors, causing panic and uncertainty. But while others are fr...
Crypto Swap Profits | Sponsored